enVVeno Medical (NVNO) Projected to Post Quarterly Earnings on Thursday

enVVeno Medical (NASDAQ:NVNO) is projected to issue its quarterly earnings data before the market opens on Thursday, March 6th. Analysts expect the company to announce earnings of ($0.35) per share for the quarter.

enVVeno Medical Price Performance

Shares of NASDAQ:NVNO opened at $3.53 on Thursday. The company has a market cap of $61.90 million, a P/E ratio of -2.74 and a beta of 1.22. enVVeno Medical has a 1 year low of $2.45 and a 1 year high of $6.97. The stock’s fifty day moving average price is $3.25 and its 200-day moving average price is $3.71.

About enVVeno Medical

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).